Orchestra BioMed Announces Q2 2026 Earnings Forecast and Reports Insider Share Sale

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) will release its second‑quarter 2026 results on Tuesday, Aug 11, before the market opens. Analysts expect the company to post a loss of $0.35 per share on revenue of $0.138 million for the quarter.

At the same time, insider Darren Sherman sold 15,000 OBIO shares under a pre‑arranged Rule 10b5‑1 trading plan for roughly $61,350, cutting his ownership by about 1.3% to 1.15 million shares. The company recently reported a quarterly loss of $0.33 per share with revenue of $0.11 million, beating earnings estimates but falling short of revenue forecasts.